Grace Therapeutics, Inc. (GRCE) shareholders

GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31

Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30

$1.81+0.00 (0.00%)

Close on Nov 13, 2026Market cap $38.08MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions

18.8%

4M of 21M shares

Institutional holders

10 new, 11 sold out

Net institutional buying

-0M

In Q2 2026

Insider trades, 12 months

24 buys · 0 sales

Net bought $839.26K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

Holder	Shares	% of class	Filing	As of
Opaleye Management Inc. Joint filing with Opaleye, L.P. (13.07%), James Silverman (13.07%)	2,748,392	13.07%	13G (passive)	Aug 5, 2026
Daniel Schneeberger Joint filing with ADAR1 Capital Management, LLC (9.90%), ADAR1 Capital Management GP, LLC (8.60%)	1,806,216	9.90%	13G (passive) amendment	Jun 30, 2026
ADAR1 Capital Management GP, LLC Joint filing with ADAR1 Capital Management, LLC (9.90%), Daniel Schneeberger (9.90%)	1,717,426	9.90%	13G (passive) amendment	Mar 31, 2026
Wilmot B. Harkey Joint filing with Nantahala Capital Management, LLC (9.99%), Daniel Mack (9.99%)	1,404,032	9.99%	13G (passive) amendment	Jun 30, 2025
AIGH Capital Management, LLC Joint filing with Hirschman Orin (9.90%)	1,322,379	9.90%	13G (passive) amendment	Mar 31, 2025
Nantahala Capital Management, LLC Joint filing with Wilmot B. Harkey (6.75%), Daniel Mack (6.75%)	1,178,203	6.75%	13G (passive) amendment	Jun 30, 2026
AIGH Capital Management LLC Joint filing with Orin Hirschman (5.90%)	907,217	5.90%	13G (passive) amendment	Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

Holder	Shares	% of GRCE	Value	Change	% of portfolio
Cerity Partners LLC	849,055	4.04%	$1.93M	–	0.00%
Eversept Partners, LP	772,900	3.67%	$1.75M	+16,300	0.09%
Bank Of America Corp /De/	494,698	2.35%	$1.12M	−25	0.00%
Vanguard Capital Management LLC	411,714	1.96%	$934.59K	+10,058	0.00%
Citadel Advisors LLC	349,740	1.66%	$793.91K	+250,998	0.00%
Maven Securities LTD	200,000	0.95%	$454.00K	New	0.01%
Cantor Fitzgerald, L. P.	200,000	0.95%	$454.00K	New	0.00%
Birchview Capital, LP	120,000	0.57%	$272.40K	+70,000	0.13%
Two Sigma Investments, LP	96,890	0.46%	$219.94K	New	0.00%
Jane Street Group, LLC	89,442	0.43%	$203.03K	−77,655	0.00%
XTX Topco Ltd	71,668	0.34%	$162.69K	+8,574	0.00%
Hrt Financial LP	62,691	0.30%	$142.00K	New	0.00%
Susquehanna International Group, Llp	49,577	0.24%	$112.54K	New	0.00%
BlackRock, Inc.	37,535	0.18%	$85.21K	New	0.00%
Rangeley Capital, LLC	26,000	0.12%	$59.02K	New	0.05%
Kestra Private Wealth Services, LLC	23,000	0.11%	$52.21K	+10,000	0.00%
UBS Group AG	16,777	0.08%	$38.08K	−9,524	0.00%
Fundamentum, LLC	11,158	0.05%	$25.33K	New	0.00%
Bnp Paribas Arbitrage, Snc	10,500	0.05%	$23.84K	+3,400	0.00%
Scientech Research LLC	10,184	0.05%	$23.12K	New	0.02%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

Quarter	Holders	Shares held	% of shares	New / added	Reduced / closed	Shares bought	Shares sold
Q2 2026	33	4M	18.8%	10 / 12	4 / 11	1M	1M
Q1 2026	34	4M	20.3%	18 / 6	4 / 5	2M	2M
Q4 2025	22	4M	20.6%	6 / 6	1 / 4	1M	0M
Q3 2025	20	4M	17.6%	2 / 4	4 / 2	0M	0M
Q2 2025	20	4M	18.1%	4 / 3	7 / 1	0M	0M
Q1 2025	17	4M	19.1%	3 / 5	7 / 1	2M	0M
Q4 2024	15	2M	9.9%	14 / 0	1 / 0	1M	0M
Q3 2024	1	1M	4.6%	1 / 0	0 / 0	1M	0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

7 funds held GRCE in Q2 2026, 92% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

Fund	Shares	% of GRCE	Value	% of fund	As of
Vanguard Total Stock Market Index Fund	400,350	1.90%	$908.79K	0.00%	Jun 30, 2026
iShares Micro-Cap ETF	35,188	0.17%	$79.88K	0.01%	Jun 30, 2026
Tiff Multi-Asset Fund	16,239	0.08%	$36.86K	0.00%	Jun 30, 2026
Vanguard Balanced Index Fund	11,364	0.05%	$25.80K	0.00%	Jun 30, 2026
Fidelity Nasdaq Composite Index Fund	5,571	0.03%	$14.32K	0.00%	May 31, 2026
1290 VT Micro Cap Portfolio	2,347	0.01%	$5.33K	0.00%	Jun 30, 2026
Total Stock Market Index Trust	778	0.00%	$1.77K	0.00%	Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

Name	Role	Shares owned	% of shares	Latest filing
Prashant Kohli	Chief Executive Officer, Director	121,357	0.58%	Sep 10, 2026
Amresh Kumar	VP Program Management	66,712	0.32%	Sep 1, 2026
Robert J. DelAversano	Principal Financial Officer	–	–	Sep 1, 2026
R. Loch Macdonald	Chief Medical Officer	–	–	Sep 1, 2026
Carrie D'Andrea	VP Clinical Operations	–	–	Apr 16, 2025
A. Brian Davis	Director	–	–	Sep 21, 2026
George Kottayil	Director	3,462,884	16.46%	Sep 21, 2026
Vimal Kavuru	Director	4,258,305	20.24%	Sep 21, 2026
Edward Neugeboren	Director	37,895	0.18%	Sep 21, 2026
Management Inc. Opaleye	10% owner	3,054,853	14.52%	Nov 5, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

Insider	Date	Transaction	Shares	Price	Value	Shares after
Management Inc. Opaleye 10% owner	Nov 5, 2026	Buy	+3,087	$1.77	$5.48K	3,054,853
Management Inc. Opaleye 10% owner	Nov 4, 2026	Buy	+5,027	$1.80	$9.06K	3,051,766
Management Inc. Opaleye 10% owner	Nov 3, 2026	Buy	+10,328	$1.79	$18.48K	3,046,739
Management Inc. Opaleye 10% owner	Oct 26, 2026	Buy	+66,411	$1.77	$117.41K	3,036,411
Management Inc. Opaleye 10% owner	Oct 22, 2026	Buy	+21,390	$1.93	$41.19K	2,970,000
Management Inc. Opaleye 10% owner	Oct 19, 2026	Buy	+4,256	$1.88	$8.00K	2,948,610
Management Inc. Opaleye 10% owner	Oct 16, 2026	Buy	+36,347	$1.89	$68.76K	2,944,354
Management Inc. Opaleye 10% owner	Oct 15, 2026	Buy	+23,485	$1.95	$45.69K	2,908,007
Management Inc. Opaleye 10% owner	Oct 14, 2026	Buy	+11,233	$1.93	$21.73K	2,884,522
Management Inc. Opaleye 10% owner	Oct 12, 2026	Buy	+7,215	$2.02	$14.57K	2,873,289
Management Inc. Opaleye 10% owner	Oct 9, 2026	Buy	+5,340	$2.04	$10.92K	2,866,074
Management Inc. Opaleye 10% owner	Oct 8, 2026	Buy	+2,077	$2.02	$4.19K	2,860,734
Management Inc. Opaleye 10% owner	Oct 5, 2026	Buy	+1,694	$2.06	$3.49K	2,858,657
Management Inc. Opaleye 10% owner	Oct 2, 2026	Buy	+20,000	$2.07	$41.37K	2,856,963
Management Inc. Opaleye 10% owner	Oct 1, 2026	Buy	+38,796	$2.04	$78.96K	2,836,963
Management Inc. Opaleye 10% owner	Sep 29, 2026	Buy	+7,849	$2.09	$16.40K	2,798,167
Management Inc. Opaleye 10% owner	Sep 23, 2026	Buy	+5,318	$2.10	$11.17K	2,790,318
Management Inc. Opaleye 10% owner	Sep 23, 2026	Buy	+5,318	$2.10	$11.17K	2,855,318
Management Inc. Opaleye 10% owner	Sep 21, 2026	Buy	+9,771	$2.10	$20.52K	2,785,000
Management Inc. Opaleye 10% owner	Sep 21, 2026	Buy	+9,771	$2.10	$20.52K	2,850,000
Prashant Kohli Chief Executive Officer, Director	Sep 9, 2026	Buy	+100,000	$2.14	$214.00K	121,357
Management Inc. Opaleye 10% owner	Sep 9, 2026	Buy	+5,836	$2.09	$12.20K	2,775,229
Management Inc. Opaleye 10% owner	Sep 8, 2026	Buy	+9,393	$2.10	$19.73K	2,769,393
Management Inc. Opaleye 10% owner	Aug 14, 2026	Buy	+11,608	$2.09	$24.26K	2,760,000
Vimal Kavuru Director, 10% owner	Sep 25, 2023	Buy	+676,371	$1.85	$1.25M	1,188,076
Donald Olds Director	Aug 31, 2023	Buy	+381	$2.05	$781	381

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float

12.74%

2M shares short

Days to cover

12.3

At 0M shares a day

Change since last report

-1.0%

From 2M shares

Short volume, 20 days

35.7%

Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Grace Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 7,889 shares on Sep 1, 2026 over the last 90 days.

See a number that looks wrong?